Aarti Drugs Limited

NSE:AARTIDRUGS.NS

490 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income 1,714.1752,241.82,699.5513,690.1391,852.8851,310.2331,245.0321,147.731950.86997.197847.604663.148322.198331.1474260.4200.933190.331
Depreciation & Amortization 514.5503.2500.489498.835487.533425.623400.63384.627365.277308.845281.194259.84219.557213.7197.1158.8149.912138.126
Deferred Income Tax 000000000000000000
Stock Based Compensation 000000000000000000
Change In Working Capital 1,027.9-1,154.6-1,873.513-1,860.927194.928-329.764-1,051.90972.556-210.611-495.828-240.912-318.855-385.162-402.3-132.7-27.2-151.74-113.763
Accounts Receivables 1,610.7-935.428-1,938.67-654.19217.312-627.19-807.696373.861-190.109-302.893-617.017-351.357000000
Inventory 342.558.2-1,106.302-891.849-786.888317.168-683.813-312.664-138.23-364.445141.932-430.114-55.788-274.3-38.956.9-38.48551.558
Accounts Payables -925.3-277.3661,171.459-314.886964.504-24.879439.623.538117.728000000000
Other Working Capital -925.3-0.0060005.137-368.096385.22-72.381-131.383-382.844111.259-329.374-128-93.8-84.1-113.255-165.321
Other Non Cash Items 45.725-248.4-630.17-779.55-27.90824.823103.908140.66227.418235.69566.379138.968209.81563.152.8220.184.76777.994
Operating Cash Flow 3,301.21,342696.3571,548.4972,507.4381,430.915697.6611,745.5741,332.9441,045.909954.265743.101366.408205.6591.2612.1283.872292.688
Investing Activities:
Investments In Property Plant And Equipment -2,263.3-1,646.7-1,519.749-881.308-479.906-742.735-745.328-1,087.928-996.579-1,069.814-1,065.233-599.964-472.655-680.9-257.4-201.7-199.958-233.035
Acquisitions Net 1.91.4540.2108.86108.468112.007016.7820-116.87500000000
Purchases Of Investments 0000-108.46800-4.014-0.027-125.51800-13.288-35.4-1.9116.5-119.513-9.247
Sales Maturities Of Investments 000026.1950000.11121.0664.6330000000
Other Investing Activites -0.15.54630.93355.658121.61814.0239.97222.1798.657121.06613.92319.54886.401-47.3-45.36.9-12.089-10.064
Investing Cash Flow -2,261.5-1,639.7-1,488.616-716.79-332.093-616.705-735.356-1,069.763-987.949-1,070.075-1,046.677-580.416-399.542-763.6-304.6-78.3-331.56-252.346
Financing Activities:
Debt Repayment -222.8-613.742-68.7-349.7-1,478.25-405.541-658.58-137.442-342.399-162.505-581.75-226.016-42.8270-95.3-487.10-13.575
Common Stock Issued 07.61,822.40501,478.2500000000018.92.100
Common Stock Repurchased -731.7-613.742-6000-253.890-240.625-2700000000-23.500
Dividends Paid -92.673-94.013-95.077-232.052-84.668-24.289-24.320-236.117-226.683-139.248-128.996-54.488-90-34.6-21.10-30.093
Other Financing Activities -133.21,479.284-138.377-229.538-1,829.877-370.873304.11-274.844-96.469403.824246.853-54.34127.158615.4-125.1-9.636.069-16.234
Financing Cash Flow -1,047.2165.4920.251-811.29-2,154.067-800.70339.165-682.286-332.58614.636107.605-183.33629.843525.4-236.1-539.236.069-59.902
Other Information:
Effect Of Forex Changes On Cash 00.009-0.0020000000-0.0010.00116.87500000
Net Change In Cash 4.702-132.3127.99120.41721.27813.5071.47-6.47512.409-9.5315.192-20.6513.584-32.650.5-5.4-11.619-19.56
Cash At End Of Period 94.383.8216.1288.1367.71346.43532.92741.73748.21235.80443.9828.78849.43952.785.234.840.19351.812